menu
    • menu

    Company profile for Scinai Immunotherapeutics

    NEW Drugs in Dev: 4
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) is a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological products primarily for the treatment of autoimmune and infectious diseases. With a state-of-the-art facility for biopharmaceutical product development and manufacturing and highly experienced pharmaceutical industry leadership, Scinai offe...
    Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) is a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological products primarily for the treatment of autoimmune and infectious diseases. With a state-of-the-art facility for biopharmaceutical product development and manufacturing and highly experienced pharmaceutical industry leadership, Scinai offers end-to-end boutique CDMO services in parallel to developing its own pipeline of diversified and commercially viable products and platforms beginning with an innovative nanosized VHH antibody (NanoAb).

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Scinai ImmunotherapeuticsIsrael Flag
    Country
    Country
    Israel
    Address
    Address
    Jerusalem BioPark Hadassah Ein Kerem campus Jerusalem
    Telephone
    Telephone
    +972 89302529
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.scinai.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/scinai/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/scinai_

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    RDD

    RDD

    Not Confirmed

    envelop Contact Supplier

    RDD

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Scinai Immunotherapeutics Unveils $2.61M Private Placement
    Scinai Immunotherapeutics Unveils $2.61M Private Placement

    24 Apr 2026

    // PR NEWSWIRE BIO

    https://www.prnewswire.com/news-releases/scinai-immunotherapeutics-announces-2-61-million-private-placement-financing-302752848.html

    PR NEWSWIRE BIO
    24 Apr 2026
    Share Share
    Scinai Restructures Into CDMO Platform, Cuts R&D Scope
    Scinai Restructures Into CDMO Platform, Cuts R&D Scope

    06 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/scinai-completes-strategic-reorganization-to-establish-dedicated-cdmo-platform-and-lean-rd-structure-outlines-2026-priorities-302734595.html

    PR NEWSWIRE
    06 Apr 2026
    Share Share
    Scinai Reports 2025 Results: CDMO Revenues Double; Recipharm Deal
    Scinai Reports 2025 Results: CDMO Revenues Double; Recipharm Deal

    01 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/scinai-reports-full-year-2025-results-with-cdmo-revenues-doubling-and-strategic-expansion-through-recipharm-collaboration-302731295.html

    PR NEWSWIRE
    01 Apr 2026
    Share Share
    Scinai Bio Expands CDMO Services And Immunology Pipeline
    Scinai Bio Expands CDMO Services And Immunology Pipeline

    19 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/scinai-immunotherapeutics-highlights-expanded-cdmo-platform-and-immunology-pipeline-at-bio-europe-spring-2026-302718695.html

    PR NEWSWIRE
    19 Mar 2026
    Share Share
    Scinai Amends PinCell Deal, Submits €12M FENG Funding Application
    Scinai Amends PinCell Deal, Submits €12M FENG Funding Application

    02 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/scinai-signs-second-amendment-to-pincell-option-agreement-and-submits-revised-12-million-non-dilutive-feng-application-to-advance-pc111-through-human-proof-of-concept-302701108.html

    PR NEWSWIRE
    02 Mar 2026
    Share Share
    Scinai Wins Israel Support for Fill-Finish Tech
    Scinai Wins Israel Support for Fill-Finish Tech

    25 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/scinai-announces-expanded-israel-innovation-authority-support-for-robotic-aseptic-fill--finish-platform-302697055.html

    PR NEWSWIRE
    25 Feb 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search